Development of mucoadhesive and thermosensitive eyedrops to improve the ophthalmic bioavailability of ibuprofen

被引:35
作者
Almeida, Hugo [1 ]
Lobao, Paulo [1 ]
Frigerio, Christian [2 ,3 ]
Fonseca, Joel [1 ]
Silva, Renata [4 ]
Quaresma, Pedro [5 ]
Sousa Lobo, Jose Manuel [1 ]
Amaral, Maria Helena [1 ]
机构
[1] Univ Porto, Fac Pharm, Dept Drug Sci, Res Ctr Pharmaceut Sci,Lab Pharmaceut Technol, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal
[2] Univ Porto, Fac Sci, Dept Chem & Biochem, Oporto, Portugal
[3] Lab Derivati Organ, Via M Barozzi 4, I-20122 Milan, Italy
[4] Univ Porto, Fac Pharm, Dept Biol Sci, UCIBIO REQUIMTE,Lab Toxicol, Oporto, Portugal
[5] Univ Porto, Fac Sci, Dept Chem, UCIBIO REQUIMTE, Oporto, Portugal
关键词
Chitosan; In situ gelling systems; Nanocarriers; Pluronic (R) F-127; Polymers; Ophthalmic; SOLID LIPID NANOPARTICLES; IN-VITRO CHARACTERIZATION; OCULAR DELIVERY-SYSTEM; SITU GELLING SYSTEMS; DRUG-DELIVERY; PHYSICOCHEMICAL CHARACTERIZATION; PHARMACEUTICAL FORMULATIONS; CHITOSAN NANOPARTICLES; ORAL DELIVERY; CARRIERS NLC;
D O I
10.1016/j.jddst.2016.04.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Topical ophthalmic formulations prepared with nanostructured lipid carriers (NLC) exhibit low bioavailability. Specific physicochemical properties of the ocular tissues, namely, temperature, pH and electrolyte composition of the pre-corneal region, can be exploited to enhance the bioavailability of colloidal nanocarriers using in situ gelling systems. The aim of this study was to enhance the ophthalmic bioavailability of NLC dispersions through the addition of a thermoresponsive polymer (Pluronic (R) F-127) and a mucoadhesive polymer (chitosan). Simulating the physiological conditions, the addition of Pluronic (R) F 127 (PF 127) caused the sol-gel transition of the colloidal dispersion upon contact with the ocular surface temperature, while the addition of chitosan (CS) led to the establishment of electrostatic interactions with the mucin present in the ocular tissues. The results also suggested that NLC-based hydrogels were biocompatible with no significant cytotoxicity observed in the Y-79 human retinoblaston-ia cell line. The addition of PF 127 and CS to NLC dispersions can enhance the bioavailability and the therapeutic efficacy of topical ophthalmic formulations. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:69 / 80
页数:12
相关论文
共 80 条
[1]   Recent advances in ocular drug delivery [J].
Achouri, Djamila ;
Alhanout, Kamel ;
Piccerelle, Philippe ;
Andrieu, Veronique .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (11) :1599-1617
[2]  
ALBASINI M, 1995, FARMACO, V50, P633
[3]  
Almeida H., 2015, CURR DRUG DELIV
[4]  
Almeida H., 2015, PHARM DEV TECHNOL
[5]   Applications of Polymeric and Lipid Nanoparticles in Ophthalmic Pharmaceutical Formulations: Present and Future Considerations [J].
Almeida, Hugo ;
Amaral, Maria Helena ;
Lobao, Paulo ;
Silva, Ana C. ;
Sousa Lobo, Jose Manuel .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2014, 17 (03) :278-293
[6]   In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations [J].
Almeida, Hugo ;
Amaral, Maria Helena ;
Lobao, Paulo ;
Sousa Lobo, Jose Manuel .
DRUG DISCOVERY TODAY, 2014, 19 (04) :400-412
[7]   Influence of Drug Incorporation, Temperature and Storage Time on the pH, Textural and Rheological Properties of Different Poloxamer Hydrogels [J].
Almeida, Hugo ;
Amaral, Maria Helena ;
Lobao, Paulo ;
Sousa Lobo, Jose Manuel .
CURRENT DRUG DELIVERY, 2013, 10 (06) :753-764
[8]   Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview [J].
Almeida, Hugo ;
Amaral, Maria Helena ;
Lobao, Paulo ;
Sousa Lobo, Jose Manuel .
EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (09) :1223-1237
[9]   Evaluation of the physical stability of two oleogels [J].
Almeida, Isabel F. ;
Bahia, M. Fernanda .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 327 (1-2) :73-77
[10]   Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications [J].
Araujo, J. ;
Gonzalez-Mira, E. ;
Egea, M. A. ;
Garcia, M. L. ;
Souto, E. B. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 393 (1-2) :167-175